|
End-of-day quote
Other stock markets
|
||
| - GHS | - |
|
| Market Cap | 5.2M 60.86M 4.52M 4.22M 3.87M 7.3M 495M 7.43M 49.72M 19.47M 247M 19.52M 19.09M 815M | P/E 2017 |
11.7x | P/E 2018 | 6.9x |
|---|---|---|---|---|---|
| Enterprise Value | 10.45M 122M 9.08M 8.48M 7.78M 14.67M 996M 14.93M 99.94M 39.14M 497M 39.24M 38.37M 1.64B | EV / Sales 2017 |
1.34x | EV / Sales 2018 | 1.05x |
| Free-Float |
26.89% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 0.00% | - | - | 915K | ||
| -2.39% | -6.36% | +45.82% | +149.66% | 1,024B | ||
| -0.76% | -4.34% | +48.74% | +49.09% | 618B | ||
| -2.33% | -4.60% | +24.30% | +64.44% | 443B | ||
| +0.68% | +0.25% | +38.47% | +31.95% | 349B | ||
| -1.66% | -1.89% | +32.18% | +37.17% | 297B | ||
| -8.96% | -9.23% | +3.57% | +3.64% | 264B | ||
| -1.37% | -5.71% | -2.10% | -44.43% | 209B | ||
| -1.63% | +0.69% | +25.48% | +64.23% | 208B | ||
| +0.72% | +0.48% | +14.53% | +73.64% | 162B | ||
| Average | -2.06% | -1.35% | +25.66% | +47.71% | 357.38B | |
| Weighted average by Cap. | -1.91% | -2.17% | +33.29% | +70.34% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 8.89M 104M 7.73M 7.22M 6.62M 12.49M 848M 12.71M 85.08M 33.32M 423M 33.4M 32.66M 1.39B | 9.91M 116M 8.61M 8.04M 7.38M 13.92M 945M 14.16M 94.81M 37.13M 471M 37.22M 36.4M 1.55B |
| Net income | 665K 7.79M 578K 540K 495K 934K 63.39M 950K 6.36M 2.49M 31.61M 2.5M 2.44M 104M | 762K 8.92M 662K 618K 567K 1.07M 72.59M 1.09M 7.29M 2.85M 36.2M 2.86M 2.8M 119M |
| Net Debt | 4.15M 48.57M 3.6M 3.36M 3.09M 5.82M 395M 5.93M 39.68M 15.54M 197M 15.58M 15.23M 650M | 5.25M 61.49M 4.56M 4.26M 3.91M 7.37M 500M 7.5M 50.23M 19.67M 250M 19.72M 19.28M 823M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- SPL Stock
Select your edition
All financial news and data tailored to specific country editions
















